American Capital Advisory’s CONMED CNMD Stock Holding History

American Capital Advisory’s Portfolio CNMD Stock Details CNMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-9	Closed	-$319	–	1178
2026 Q1	$319	Buy	+9	New	+$366	﹤0.01%	953

Other funds holding CNMD

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Cooke & Bieler Philadelphia, Pennsylvania $8.65B AUM 9.66% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return

Glenmede Trust Philadelphia, Pennsylvania $22.7B AUM

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

TCM

Tributary Capital Management Omaha, Nebraska $1.22B AUM 44.12% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return

Nordea Investment Management Stockholm, Sweden $123B AUM 38.85% 1-Year Est. Return

American Capital Advisory's CNMD Position: Q2 2026 in Review

American Capital Advisory sold out of CONMED (CNMD) in Q2 2026, closing a stake of 9 shares — an estimated $319 sold.

American Capital Advisory first reported a position in CNMD in Q1 2026 and held it in 1 quarter. The position peaked at $319 in Q1 2026. 101 funds tracked by Wall St. Rank hold CNMD as of Q2 2026.

American Capital Advisory reported no remaining CONMED position as of Q2 2026 after selling out during the quarter.
American Capital Advisory sold 9 CONMED shares in Q2 2026, an estimated $319.
American Capital Advisory first reported a position in CONMED in Q1 2026 and held it in 1 quarter.
American Capital Advisory's CONMED position peaked at $319 in Q1 2026.
101 funds tracked by Wall St. Rank held CONMED as of Q2 2026.

Based on American Capital Advisory's 13F filing for Q2 2026, filed 28 Jul 2026.